| Dr Zsofia Geck, MD | |
|
3050 Bee Ridge Rd, Sarasota, FL 34239-7101 | |
| (941) 342-9750 | |
| (941) 342-9788 |
| Full Name | Dr Zsofia Geck |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 20 Years |
| Location | 3050 Bee Ridge Rd, Sarasota, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568551182 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | ME103132 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sarasota Memorial Hospital | Sarasota, FL | Hospital |
| Upmc Presbyterian Shadyside | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mark A. Lupo,m.d.,p.a. | 3072555192 | 4 |
News Archive
Recent studies have shown that a 64-detector CT angiography utilizing prospective electrocardiographic gating produces a quality image but considerably reduced patient radiation dose when compared to retrospective ECG gating, according to research being presented at the 2011 American Roentgen Ray Society's annual meeting.
Drug-resistant bacteria could lead to more deaths than cancer by 2050, according to a report commissioned by the United Kingdom in 2014 and jointly supported by the U.K. government and the Wellcome Trust.
The American Society of Anesthesiologists (ASA) today released results from the inaugural Vital Health Report, which demonstrate that Americans associate good health with lifestyle behaviors and habits, but overlook their key Vital Health measures (e.g. cholesterol, body mass index, blood pressure, disease screenings), some of the true indicators of overall health. The report further reveals that Americans believe they know more about their Vital Health than they actually do.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced the closing of the underwriters' exercise of their over-allotment option to purchase an additional 604,492 shares of Anthera's common stock, at a price of $7.00 per share.
In the latest clinical trial for a technique to detect pancreatic cancer, researchers found they could differentiate cells that are cancerous from those that are benign, pre-cancerous, or even early stage indicators called mucinous cystic lesions.
› Verified 8 days ago
| Entity Name | Mark A. Lupo,m.d.,p.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982644464 PECOS PAC ID: 3072555192 Enrollment ID: O20050527000524 |
News Archive
Recent studies have shown that a 64-detector CT angiography utilizing prospective electrocardiographic gating produces a quality image but considerably reduced patient radiation dose when compared to retrospective ECG gating, according to research being presented at the 2011 American Roentgen Ray Society's annual meeting.
Drug-resistant bacteria could lead to more deaths than cancer by 2050, according to a report commissioned by the United Kingdom in 2014 and jointly supported by the U.K. government and the Wellcome Trust.
The American Society of Anesthesiologists (ASA) today released results from the inaugural Vital Health Report, which demonstrate that Americans associate good health with lifestyle behaviors and habits, but overlook their key Vital Health measures (e.g. cholesterol, body mass index, blood pressure, disease screenings), some of the true indicators of overall health. The report further reveals that Americans believe they know more about their Vital Health than they actually do.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced the closing of the underwriters' exercise of their over-allotment option to purchase an additional 604,492 shares of Anthera's common stock, at a price of $7.00 per share.
In the latest clinical trial for a technique to detect pancreatic cancer, researchers found they could differentiate cells that are cancerous from those that are benign, pre-cancerous, or even early stage indicators called mucinous cystic lesions.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Zsofia Geck, MD 3050 Bee Ridge Rd, Sarasota, FL 34239-7101 Ph: (941) 342-9750 | Dr Zsofia Geck, MD 3050 Bee Ridge Rd, Sarasota, FL 34239-7101 Ph: (941) 342-9750 |
News Archive
Recent studies have shown that a 64-detector CT angiography utilizing prospective electrocardiographic gating produces a quality image but considerably reduced patient radiation dose when compared to retrospective ECG gating, according to research being presented at the 2011 American Roentgen Ray Society's annual meeting.
Drug-resistant bacteria could lead to more deaths than cancer by 2050, according to a report commissioned by the United Kingdom in 2014 and jointly supported by the U.K. government and the Wellcome Trust.
The American Society of Anesthesiologists (ASA) today released results from the inaugural Vital Health Report, which demonstrate that Americans associate good health with lifestyle behaviors and habits, but overlook their key Vital Health measures (e.g. cholesterol, body mass index, blood pressure, disease screenings), some of the true indicators of overall health. The report further reveals that Americans believe they know more about their Vital Health than they actually do.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced the closing of the underwriters' exercise of their over-allotment option to purchase an additional 604,492 shares of Anthera's common stock, at a price of $7.00 per share.
In the latest clinical trial for a technique to detect pancreatic cancer, researchers found they could differentiate cells that are cancerous from those that are benign, pre-cancerous, or even early stage indicators called mucinous cystic lesions.
› Verified 8 days ago
Fadi Kayali, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 600 N Cattlemen Rd, Suite 200, Sarasota, FL 34232 Phone: 941-377-9993 Fax: 941-343-0026 | |
Dr. Eduardo Jose Lazaro, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 5731 Bee Ridge Rd, Sarasota, FL 34233 Phone: 727-808-5824 | |
Dr. Scott D. Lunin, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1970 Golf St, Sarasota, FL 34236 Phone: 941-957-1000 Fax: 941-951-2117 | |
Dr. Robert L Oppenheimer, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1921 Waldemere St, Suite 605, Sarasota, FL 34239 Phone: 941-917-8100 Fax: 941-917-6334 | |
Edward Renan Bermudez, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3920 Bee Ridge Rd, Bldg E, Suite F-201, Sarasota, FL 34233 Phone: 941-917-8744 Fax: 941-917-8749 | |
Dr. Stephen C Culp, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3830 Bee Ridge Rd, Suite 201, Sarasota, FL 34233 Phone: 941-929-7272 Fax: 941-929-1044 | |
Dr. Suzanne R Lutton, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 5951 Cattleridge Ave Ste 100, Sarasota, FL 34232 Phone: 941-379-1850 Fax: 941-379-1855 |